Clinical trial
An Open-label, Multi-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of 16 Week Day and Night Automated Closed-loop Glucose Control Under Free Living Conditions Compared to Sensor Augmented Insulin Pump Therapy in Older Adults With Type 1 Diabetes.
NCT04025762 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multi-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of 16 Week Day and Night Automated Closed-loop Glucose Control Under Free Living Conditions Compared to Sensor Augmented Insulin Pump Therapy in Older Adults With Type 1 Diabetes.
- Lead sponsor
- University of Cambridge
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- August 20, 2021
- Enrollment
- 38 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
arrythmia, hypoglycemia, type 1 diabetes mellitus